You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指跌幅擴至逾600點 美團/舜宇/藥明生物吐逾6%-7% 惟中銀逆市續升逾2%
阿思達克 03-04 10:37
美國2月ISM服務業指數及2月ADP私企就業職位增速長緩速度遠超預期,加上債息回升,投資者繼續沽售市值較高科技股,美股在科技股主導連跌兩天,尤其是納指續挫2.7%,標普續跌1.3%;但金融、能源及部分工業股造好,支持道指僅反覆續吐0.4%。不過,美股期貨全面續跌0.2%-0.5%,納指期貨續跑輸報12,615。亞太區主要股市全面回吐,其中菲股、澳股、台股、韓股及日經跌1.1%-1.8%;上證及深成跌幅擴至1.4%及2.6%,分別報3,527及14,542。

本港今年1月零售額按年跌幅意外進一步略擴至13.6%(前值續降13.2%),為半年來最傷,且已連跌24個月,市場原預期降幅收窄至11.4%。

憧憬人行「降準」,恆指繼昨天在金融板塊發力飆升帶動急彈784點或2.7%重越20天線後,今早在重磅股騰訊(00700.HK)、美團(03690.HK)及銀娛(00027.HK)低開逾3%拖累低開354點或1.2%報29,525,跌幅持續擴至627點或2.1%,報29,253。

藍籌股普遍下跌,藥明生物(02269.HK)挫7.5%報94.75元為最傷藍籌;其次為舜宇(02382.HK)及美團分別回吐6.8%及6.5%,分別低見190元及344.6元。騰訊回吐3.2%曾低見696元,股價失守10天線(702元)。

港交所(00388.HK)、百威亞太(01876.HK)、小米(01810.HK)、全年多賺30%末期息年增41%創科(00669.HK)、安踏(02020.HK)及銀娛(00027.HK)及吉利汽車(00175.HK)吐逾3%-4.5%,前者失守50天線(487.4元),曾低見480.8元。不過,恆生(00011.HK)、港鐵(00066.HK)及中銀(02388.HK)逆升0.3%-2.3%,後者最高見27.4元,現造26.95元,續升2.3%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account